Hong M - Search Results

1

Acute myeloid leukemia in four patients with t(8;21) treated with all-trans retinoic acid as a single agent.

Qian SX, Li JY, Hong M, Qiu HR, Fan L, Xu W. Qian SX, et al. Among authors: hong m. Leuk Lymphoma. 2008 May;49(5):998-1001. doi: 10.1080/10428190801959018. Leuk Lymphoma. 2008. PMID: 18464121 No abstract available.

2

[Clinical features and prognosis of low triiodothyronine syndrome in patients with acute myeloid leukemia].

Li LZ, Hu JH, Xu ZY, Hong M, Sun Q, Qian SX, Liu WJ. Li LZ, et al. Among authors: hong m. Zhonghua Xue Ye Xue Za Zhi. 2021 Nov 14;42(11):923-929. doi: 10.3760/cma.j.issn.0253-2727.2021.11.007. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 35045654 Free PMC article. Chinese.

3

[Allogeneic peripheral blood stem cell transplantation for 75 cases of hematologic malignancies].

Wu HX, Qian SX, Hong M, Zhang YP, Lu H, Zhang R, Zhang XY, Chen LJ, Lu RN, Zhang SJ, Liu P, Ge Z, Fan L, Wang L, Xu J, Tian T, Zhu Y, Qiu HX, Xu W, Sheng RL, Li JY. Wu HX, et al. Among authors: hong m. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Dec;16(6):1330-3. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 19099638 Chinese.

4

[Abnormality of serum immunoglobulin in peripheral blood of patients with chronic lymphocytic leukemia].

Zhu YD, Xu W, Miao KR, Cao X, Fan L, Liu Q, Yao L, Wu YJ, Hong M, Li JY. Zhu YD, et al. Among authors: hong m. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Oct;17(5):1159-62. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 19840442 Chinese.

5

Prognostic impact of Epstein-Barr virus (EBV)-DNA copy number at diagnosis in chronic lymphocytic leukemia.

Liang JH, Gao R, Xia Y, Gale RP, Chen RZ, Yang YQ, Wang L, Qu XY, Qiu HR, Cao L, Hong M, Wang R, Wang Y, Fan L, Chen YY, Hu ZB, Li JY, Xu W. Liang JH, et al. Among authors: hong m. Oncotarget. 2016 Jan 12;7(2):2135-42. doi: 10.18632/oncotarget.6281. Oncotarget. 2016. PMID: 26539641 Free PMC article.

6

[Monitoring of bcr/abl fusion gene by interphase-dual-color and dual-fusion fluorescence in situ hybridization in CML after allo-HSCT].

Qian SX, Li JY, Zhang R, Hong M, Qiu HR, Li L, Xu W, Sheng RL, Wu HX. Qian SX, et al. Among authors: hong m. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Jun;14(3):577-81. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006. PMID: 16800946 Chinese.

7

High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid.

Wu W, Zhu H, Fu Y, Shen W, Miao K, Hong M, Xu W, Fan L, Young KH, Liu P, Li J. Wu W, et al. Among authors: hong m. Oncotarget. 2016 Apr 19;7(16):21631-43. doi: 10.18632/oncotarget.7795. Oncotarget. 2016. PMID: 26950276 Free PMC article.

8

miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.

Zhu DX, Zhu W, Fang C, Fan L, Zou ZJ, Wang YH, Liu P, Hong M, Miao KR, Liu P, Xu W, Li JY. Zhu DX, et al. Among authors: hong m. Carcinogenesis. 2012 Jul;33(7):1294-301. doi: 10.1093/carcin/bgs179. Epub 2012 May 18. Carcinogenesis. 2012. PMID: 22610076

9

Low expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemia.

Miao Y, Fan L, Wu YJ, Xia Y, Qiao C, Wang Y, Wang L, Hong M, Zhu HY, Xu W, Li JY. Miao Y, et al. Among authors: hong m. Oncotarget. 2016 Mar 22;7(12):13551-62. doi: 10.18632/oncotarget.6948. Oncotarget. 2016. PMID: 26910908 Free PMC article.

10

Overexpressed BAG3 is a potential therapeutic target in chronic lymphocytic leukemia.

Zhu H, Wu W, Fu Y, Shen W, Miao K, Hong M, Xu W, Young KH, Liu P, Li J. Zhu H, et al. Among authors: hong m. Ann Hematol. 2014 Mar;93(3):425-35. doi: 10.1007/s00277-013-1883-1. Epub 2013 Aug 25. Ann Hematol. 2014. PMID: 23978946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,333 results

Search Page

Filters